Suppr超能文献

DICER1 综合征:阐明一种多效性肿瘤易感性综合征的诊断、临床特征和管理意义。

DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome.

机构信息

Section of Cancer Genetics, Institute of Cancer Research and Royal Marsden Hospital, , 15 Cotswold Road, Sutton SM2 5NG, UK.

出版信息

J Med Genet. 2011 Apr;48(4):273-8. doi: 10.1136/jmg.2010.083790. Epub 2011 Jan 25.

Abstract

BACKGROUND

Constitutional DICER1 mutations were recently reported to cause familial pleuropulmonary blastoma (PPB).

AIM

To investigate the contribution and phenotypic spectrum of constitutional and somatic DICER1 mutations to cancer.

METHODS AND RESULTS

The authors sequenced DICER1 in constitutional DNA from 823 unrelated patients with a variety of tumours and in 781 cancer cell lines. Constitutional DICER1 mutations were identified in 19 families including 11/14 with PPB, 2/3 with cystic nephroma, 4/7 with ovarian Sertoli-Leydig-type tumours, 1/243 with Wilms tumour (this patient also had a Sertoli-Leydig tumour), 1/1 with intraocular medulloepithelioma (this patient also had PPB), 1/86 with medulloblastoma/infratentorial primitive neuroectodermal tumour, and 1/172 with germ cell tumour. The inheritance was investigated in 17 families. DICER1 mutations were identified in 25 relatives: 17 were unaffected, one mother had ovarian Sertoli-Leydig tumour, one half-sibling had cystic nephroma, and six relatives had non-toxic thyroid cysts/goitre. Analysis of eight tumours from DICER1 mutation-positive patients showed universal retention of the wild-type allele. DICER1 truncating mutations were identified in 4/781 cancer cell lines; all were in microsatellite unstable lines and therefore unlikely to be driver mutations.

CONCLUSION

Constitutional DICER1 haploinsufficiency predisposes to a broad range of tumours, making a substantial contribution to PPB, cystic nephroma and ovarian Sertoli-Leydig tumours, but a smaller contribution to other tumours. Most mutation carriers are unaffected, indicating that tumour risk is modest. The authors define the clinical contexts in which DICER1 mutation testing should be considered, the associated tumour risks, and the implications for at-risk individuals. They have termed this condition 'DICER1 syndrome'. ACCESSION NUMBERS: The cDNA Genbank accession number for the DICER1 sequence reported in this paper is NM_030621.2.

摘要

背景

最近有报道称,DICER1 基因突变会导致家族性肺胸膜胚细胞瘤(PPB)。

目的

研究胚系和体细胞 DICER1 突变对癌症的贡献和表型谱。

方法和结果

作者对 823 名患有多种肿瘤的无亲缘关系患者和 781 个癌细胞系的 DICER1 进行了测序。在 19 个家族中发现了胚系 DICER1 突变,包括 14 个家族中的 11 个患有 PPB、3 个家族中的 2 个患有囊性肾瘤、7 个家族中的 4 个患有卵巢 Sertoli-Leydig 型肿瘤、243 个家族中的 1 个患有 Wilms 瘤(该患者还患有 Sertoli-Leydig 肿瘤)、1 个家族中的 1 个患有眼内 medulloepithelioma(该患者还患有 PPB)、86 个家族中的 1 个患有髓母细胞瘤/幕下原始神经外胚层肿瘤、172 个家族中的 1 个患有生殖细胞肿瘤。在 17 个家族中对遗传情况进行了研究。在 25 名亲属中发现了 DICER1 突变:17 名亲属未受影响,1 名母亲患有卵巢 Sertoli-Leydig 肿瘤,1 名同父异母的兄弟患有囊性肾瘤,6 名亲属患有非毒性甲状腺囊肿/甲状腺肿。对 8 名 DICER1 突变阳性患者的肿瘤进行分析,结果显示野生型等位基因普遍保留。在 781 个癌细胞系中发现了 4 个 DICER1 截断突变;所有突变均发生在微卫星不稳定的细胞系中,因此不太可能是驱动突变。

结论

胚系 DICER1 杂合性缺失易患多种肿瘤,对 PPB、囊性肾瘤和卵巢 Sertoli-Leydig 肿瘤有较大的贡献,但对其他肿瘤的贡献较小。大多数突变携带者未受影响,表明肿瘤风险适度。作者定义了应考虑进行 DICER1 突变检测的临床情况、相关肿瘤风险以及对高危个体的影响。他们将这种情况称为“DICER1 综合征”。

登录号

本文报告的 DICER1 序列的 cDNA Genbank 登录号为 NM_030621.2。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验